Podcasts about Digital health

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Healthcare is filled with great ideas, promising technologies, and passionate clinicians, but why do so many innovation efforts fail? In this episode, Dale Ellicott joins Dr. Andrea Austin to explore what it really takes to create sustainable change in healthcare. From his early experiences introducing groundbreaking rehabilitation technologies to his current work at Rely Health, Dale shares lessons about resistance to change, organizational alignment, and the importance of putting patients first. Together, they discuss the realities of value-based care, the challenges clinicians face when navigating fragmented healthcare systems, and the growing role of AI in supporting, not replacing human connection. Dale explains how Rely Health combines agentic AI with human care navigators to help patients schedule appointments, access transportation, connect with primary care, and overcome barriers that often lead to poor outcomes and avoidable readmissions. The conversation offers practical guidance for clinicians, leaders, and innovators who want to move beyond pilot programs and build solutions that truly improve healthcare delivery. They discussed: How a values-based decision shaped Dale's career in healthcare innovation Why healthcare organizations struggle to adopt new technology The dangers of "pilotitis" and failed innovation projects How AI-powered care navigation improves patient follow-up Lessons for clinicians who want to become successful change-makers

Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself. Why healthcare AI fundraising has become a tale of two marketsThe two questions dominating investor meetings in 2026The metrics VCs are looking for todayThe debate over whether investors should abandon traditional ownership targetsWhy high valuations can be both a gift and a trap for founders —Show notes:Submit questions for our Eric Larsen healthcare AI Q&A here Part I: AI ate digital health (and what that means for fundraising)Part II: Convicted or disciplined: How healthcare VCs are split on investing—

Jessica from SomX chatted through all the best news from this week with Heather Cook, Fiona McCormick and Toby Croft.

From Clinic to Consumer On How AI Is Reshaping the Entire Health Experience Host: Megan Antonelli Guest: Kenn Harper, GM, Dragon and DAX Copilot, Microsoft Join host Megan Antonelli who sits down with Kenneth Harper, General Manager for Dragon and DAX Copilot at Microsoft, to explore two major moves reshaping health AI. Dragon Copilot has now scaled to more than 100,000 clinical deployments across nine countries, spanning physician, nursing, and radiology workflows, while the newly launched Copilot Health gives patients a unified view of their health data from wearables, EHRs, and lab results, all between clinical visits. Kenneth unpacks what this dual-track strategy means for health systems, clinical teams, and patients, and what health system leaders need to be thinking about right now. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us Fan MailThe World Health Organization projects a global shortage of 10 million healthcare workers by 2030. No training pipeline can close that gap. The only path forward runs through technology.Dr. Bertalan Meskó, Founder & Director of the Medical Futurist Institute, joins host David E. Williams to discuss why digital health is first and foremost a cultural transformation rather than a technological one, and why the most important thing any health system leader can do right now is learn how to use AI as the connective interface between an increasingly complex ecosystem of tools, patients, and clinical teams.

At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"Do nothing for us without us." According to today's guest Robyn Bussey, that operating principle is the basis for effective community health work. "You don't go into a community and dictate. You go and listen and trust and be a partner," she adds. As you'll learn in this enlightening conversation, Bussey is following that approach in her current work as Just Health Director at the Partnership for Southern Equity, an Atlanta-based nonprofit advancing racial equity and shared prosperity across the South.  On this episode of Raise the Line from Elsevier, Bussey provides illuminating  examples of community-rooted work in South Fulton County and rural Georgia, and explains why community health workers may be the most underutilized asset in addressing health disparities. This wide-ranging interview with host Michael Carrese also explores: Bussey's candid perspective on what happened to the surge of interest in health equity that occurred during COVID; Why life expectancy gains in many Southern states have lagged behind the rest of the country; Her advice to students and early-career clinicians about where they're needed most.   Mentioned in this episode:  Partnership for Southern Equity If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This episode of Quality Matters examines the growing role of digital wellness and chronic condition management programs and the challenge of measuring what truly matters. Host Rachel Harrington is joined by Peter Robertson of the Purchasing Business Group on Health and California Quality Collaborative and Kevin Masci of Omada Health to discuss how digital health solutions can help address rising healthcare costs, workforce shortages and fragmented care experiences. Peter and Kevin explain why meaningful engagement goes far beyond app downloads and login counts. Instead, successful programs focus on sustained participation, patient-centered goal setting, integration with primary care and measurable improvements in health outcomes. The conversation explores how employers, health plans and providers are evaluating digital solutions through clinical outcomes, patient-reported outcomes, utilization measures and value-based contracting arrangements. The guests also discuss one of the most important challenges facing digital health: trust. Privacy, transparency, data security and clear communication about how patient data is collected and used all play critical roles in long-term adoption. The episode concludes with a Patient Voice segment featuring Brandee Hicks, who shares her firsthand experiences using digital health tools, highlighting both the convenience they offer and the ongoing challenges around interoperability, digital literacy and maintaining support after programs end.     Highlights Beyond Logins and Clicks Meaningful engagement isn't about how often patients open an app. It's about helping people achieve their health goals through sustained participation and measurable outcomes. Measuring What Matters Guests discuss the growing use of clinical outcomes, patient-reported outcomes, utilization data and value-based contracting to assess digital health program performance. Trust Is Essential Digital health solutions must address concerns around privacy, transparency, data security and how patient information is stored and shared. The Patient Perspective Brandee Hicks shares how digital tools can improve organization, access and self-management while also revealing gaps in continuity, support and interoperability. Looking Ahead The future of digital health depends on better integration with primary care, more personalized engagement strategies and stronger measurement frameworks that prioritize patient outcomes.     Key Quote: "If we're really serious about improving health outcomes, we have to move beyond measuring clicks and logins. The real question is whether people are achieving meaningful progress toward their health goals—and whether these programs are creating lasting value for patients, providers and purchasers alike." — Kevin Masci     Time Stamps: (02:20) Meet Peter Robertson (03:45) Meet Kevin Masci (05:53) Why Digital Solutions Matter (10:01) Care Coordination, Not Care Fragmentation (11:52) Defining Meaningful Patient Engagement (15:07) Why Consistent Measurement Matters (18:32) Measuring Outcomes in Value-Based Contracts (21:12) Data Stratification, Risk Adjustment and Performance Guarantees (27:22) Privacy, Trust and Transparency in Digital Health (30:44) The Future of Digital Wellness and Chronic Care Management (35:08) Patient Voice: Brandee Hicks (40:25) Patient Challenges, Access and Continuity of Care (45:23) Key Takeaways and Closing Thoughts     Dive Deeper: Connect with Peter Robertson Connect with Kevin Masci Connect with Brandee Hicks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What can the rest of the world learn from one of Europe's most impressive digital health ecosystems? This week on Pulse: Amplify, Louise and George sit down with Inma Rodríguez, Market Intelligence Manager at ACCIÓ (Catalonia Trade & Investment), who led the Digital Health in Catalonia Report 2026 — a rare regional analysis that benchmarks Catalonia against the US, Asia and the rest of Europe.Inma unpacks where Europe really sits in the global market (and whether it's keeping pace or falling behind), why digital health growth is settling into a more mature ~5% a year, and whether Europe's focus on regulation, interoperability and data governance is a brake or a long-term advantage. She explains how Catalonia became the 4th region in the world for foreign health-innovation investment, the role anchor investors like AstraZeneca play, and why 65% of the region's digital health companies are building with AI. The conversation also turns to the honest gap revealed in Catalonia's hospital survey — strong ambition, moderate maturity — and the cultural, budget and patient-habit barriers slowing real-world implementation. Inma closes with the seven trends shaping 2026, why AI, personalised medicine and health data spaces top her list, and the 2030 headline she most wants to see.A data-rich conversation for anyone who wants evidence, not hype, about where digital health is heading.Stryker Vocera's Initial Delays Diagnosis Quiz LinkCheck out the ACCIO Report hereConnect with Inma on LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

How can we use digital technology to address children's physical and mental health needs and shift from reactive to anticipatory, personalised care? This episode is the first of a series on research and child health and discusses the role of technology in transforming child health. Professor Paul Dimitri, Director of Research and Innovation at Sheffield Children's NHS Foundation Trust and paediatric endocrinology consultant talks with Nish Talawila Da Camara, Head of Research and Evidence. Paul outlines how digital tools, data and artificial intelligence can be used to build a more proactive and humane system for addressing children and young people's health. There are many exciting advancements in the world of digital health technology, from new infrastructure like the incoming National Centre for Child Health Technology to advancements like remote monitoring, digital twins and AI. But we now face new challenges: Paul emphasises the need for child-focused digital standards and safeguarding measures. As children and young people's physical and mental needs are rising, 'the real opportunity isn't the technology itself. It's what we choose to do with it.' Read our news page summary and download the transcript from episode 1 - on RCPCH website Discover more of our podcasts - on RCPCH Learning The views, thoughts and opinions expressed in this podcast relates only to the speaker and not necessarily to their employer, organisation, RCPCH or any other group or individual. About Paul Professor Paul Dimitri is a Consultant in Paediatric Endocrinology and the Director of Research and Innovation at Sheffield Children's NHS Foundation Trust. He has been working in the field of Paediatrics since 1998 and Paediatric Endocrinology since 2004.  Paul took office as Vice President for Science and Research at the Royal College of Paediatrics and Child Health in early 2022 and is leading on the development of the National Centre for Child Health Technology, aiming to bring together industry, universities, healthcare professionals, children and young people and their families to develop the most advanced healthcare technologies for children worldwide.

This week on the You Are Dope Podcast, Kennedy shares her deeply personal journey of knowing something wasn't right with her health and the frustration of repeatedly being told that nothing was wrong.What followed was years of unanswered questions, self-doubt, and the challenge of advocating for herself when the people she trusted weren't listening.Joining the conversation is Dr. Brandi Sinkfield, a board-certified anesthesiologist, healthcare leader, and founder of Women's Digital Health. She is passionate about helping patients navigate the healthcare system, advocate for themselves, and improve communication with their medical providers—especially when concerns are dismissed or overlooked. Her work focuses on women's health, patient advocacy, and creating better healthcare experiences for all.  Together, we discuss: trusting yourself when something feels off  advocating for your health  navigating difficult healthcare experiences  the importance of being heard  practical ways to speak up for yourself  lessons for patients, families, and healthcare providers This is a conversation about courage, persistence, and the power of trusting your own voice.Because sometimes advocating for yourself isn't optional—it's necessary.

Dr. Sarah Matt trained as a burn surgeon, working in a field where patients arrive with catastrophic injuries and survival depends on speed, skill, and resources. She left the bedside after confronting a limit that medicine does not like to admit. One physician can only see so many people in a day. The system surrounding those patients decides the rest. She moved into health technology, held leadership roles in startups, and built global infrastructure at Oracle to scale care across populations. Then she watched billions of dollars in digital health and AI initiatives stall out when they hit real clinical environments.This episode follows that pivot from surgeon to strategist and back into direct patient care in rural New York, where she now treats uninsured patients, migrant workers, and communities pushed to the margins. The conversation centers on a persistent failure across healthcare systems. Products get built for regulators, executives, and investors instead of the people who use them. The result shows up in failed adoption, broken workflows, prior authorization delays, and rising physician burnout.The discussion cuts through health policy language and lands on lived consequence. The system rewards speed over usability, scale over trust, and compliance over care. Patients absorb the fallout. Physicians carry the liability. The incentives remain intact.RELATED LINKSDr. Sarah MattThe Borderless Healthcare RevolutionThe Clinical RealistJessica FedererSovatoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI ethicist Jess Morley: these chatbots are giving medical advice — so regulate them as medical devices. Part of The Agentic Patient, a Faces of Digital Health series on how patients actually use AI — which tools, which prompts, which safeguards. In this episode, host Tjaša Zajc sits down with Dr Jess Morley, Associate Research Scientist at the Yale Digital Ethics Center and a former AI subject-matter expert at the UK Department of Health and Social Care, for a clear-eyed account of where health AI is going wrong — and how to use it well anyway. Morley argues we systematically overestimate what these tools can do and underestimate the harm. She makes the case for "skeptical optimism," explains why bioethics principles built for one-to-one care break down against many-to-many AI harms, and reframes ambient scribes as inference engines rather than transcription services — with real consequences for coding, billing and patient records. Then she gets practical: the guardrails, prompts and habits patients (and clinicians) can use today. Guest: Dr Jessica Morley — Associate Research Scientist, Yale Digital Ethics Center; formerly UK Department of Health and Social Care and the Bennett Institute, University of Oxford. What the conversation covers: - Why "skeptically optimistic" is the honest position on health AI - AI adoption as "a hammer looking for nails" — and what needs-led design would look like instead - OpenEvidence, EU rules and the question of regulatory capture - The DeepMind–Royal Free case and why law alone isn't enough - Beneficence, non-maleficence, autonomy, justice — and where they fail for AI - Ambient AI scribes, miscoding, billing inflation and phantom tests - Paid vs free models and the widening access gap - The "ask why" rule and knowing when to walk away from a chatbot - Red-teaming your own assumptions and playing models off each other - Building a personal "harness" with skills so AI works from your history - The last-mile problem and the case for regulating LLMs as medical devices - Whether AI is narrowing how clinicians think Chapters: 02:50 — Intro: The Agentic Patient and the case for skeptical optimism 05:52 — "A hammer looking for nails": adoption pressure without a plan 07:25 — OpenEvidence, EU rules and regulatory capture 09:42 — The DeepMind–Royal Free lesson: why law needs ethics 13:29 — The bioethics principles and what they were built to do 19:40 — Autonomy, consent and the ambient-scribe problem 21:49 — Scribes as inference engines: miscoding, fraud and phantom tests 29:06 — Paid vs free models and the access gap 33:25 — Using AI safely: the "ask why" rule 37:38 — Knowing when to walk away: engagement design and degradation 44:58 — Red-teaming and playing models off each other 49:00 — Harnesses and skills: making the model work for you 51:38 — The last-mile problem and regulating AI as a medical device 58:00 — Does AI narrow the clinician's mind? The Agentic Patient series: https://www.facesofdigitalhealth.com/agentic-patient-blog Website: https://www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com LinkedIn: https://www.linkedin.com/company/faces-of-digital-health

Dr. Ami Bhatt is the Chief Innovation Officer for the American College of Cardiology and Chair of FDA's Digital Health Advisory Committee.We discuss the intersection of medicine and technology, highlighting the impact of digital health on chronic disease management, patient education, and access to care. The conversation delves into telemedicine, remote monitoring, patient empowerment, integrative care, and the future of predictive and preventative healthcare.This episode was sponsored by Ardelyx.

Despite cervical cancer being nearly 100% preventable through routine screening, almost one in three U.S. women are behind, and the numbers have been moving in the wrong direction for a decade. Kara Egan, CEO and Co-Founder of Teal Health, left a career as a health tech investor to fix one of the most overlooked gaps in women's preventive care. In May 2025, Teal received the only FDA authorization for at-home cervical cancer screening, and just seven months later had scaled to all 50 states. In this conversation, Kara breaks down what it actually takes to redesign a screening process that hasn't meaningfully changed in 80 years, how regulatory alignment and updated clinical guidelines are reshaping the landscape, and what at-home diagnostics signal for the future of preventive care and women's health access broadly. Kara Egan, CEO and Co-Founder, Teal Health Megan Antonelli, CEO, HealthIMPACT Live

Autonomous vehicles may be the closest real-world example of AI operating in life-and-death situations at scale. Justin Norden believes healthcare has a lot to learn from how that industry approached safety, testing, adoption, and trust. This week, Michael and Halle sit down with the founder and CEO of Qualified Health, fresh off the company's $125 million Series B, to discuss why healthcare organizations need to think differently about deploying AI. Justin shares how his experience at Stanford, Apple, Waymo, and in healthcare investing shaped his view that health systems need AI infrastructure, governance, and workforce buy-in, not just another point solution.We cover:What healthcare can learn from Waymo's approach to safe AI deploymentWhat founders need to understand about building around EpicWhy health systems need to treat AI as a CEO-level priority, not an innovation projectHow Qualified Health is helping systems deploy, monitor, and measure AI workflowsWhy governance, safety, and ROI matter as much as model performanceWhy clinicians are right to be skeptical about AI liabilityAbout our guest:Justin Norden, MD is Co-Founder and CEO of Qualified Health building the trusted platform for health system AI. Additionally, he has been an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research where his research and teaching focused on AI in medicine and digital health where he founded and still teaches courses on digital health and generative AI in medicine. Previously, Dr. Norden was Co-Founder and CEO of Trustworthy AI, a company focused on algorithm safety and trust, which was acquired by Waymo (Google Self-Driving). He was a Partner at GSR Ventures leading investments in healthcare and AI, worked on the healthcare team at Apple, and helped start the Stanford Center for Digital Health. Dr. Justin Norden received an MD and MBA from Stanford University, an MPhil in Computational Biology from the University of Cambridge, and a BA in Computer Science from Carleton College.—

Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company's 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.

1 in 3 Women Unscreened On Closing the Cervical Cancer Gap Despite cervical cancer being nearly 100% preventable through routine screening, almost one in three U.S. women are behind, and the numbers have been moving in the wrong direction for a decade. Kara Egan, CEO and Co-Founder of Teal Health, left a career as a health tech investor to fix one of the most overlooked gaps in women's preventive care. In May 2025, Teal received the only FDA authorization for at-home cervical cancer screening, and just seven months later had scaled to all 50 states. In this conversation, Kara breaks down what it actually takes to redesign a screening process that hasn't meaningfully changed in 80 years, how regulatory alignment and updated clinical guidelines are reshaping the landscape, and what at-home diagnostics signal for the future of preventive care and women's health access broadly. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

This is the third and final edition of our series on young peoples' digital health and human rights.Today we're talking to Alberta Nadutey - a research officer for working on the Digital Health and Rights project about how young people in Ghana interact with digital health, and Minh Anh a young person from the Vietnam community advisory team about her participation in the research in Vietnam, and what she sees as the biggest digital health concerns as a medical student interested in public health policy.LinksDHRP report: https://digitalhealthandrights.com/resource-library/report-paying-the-costs-of-connection/Ghana policy brief DHRP: https://digitalhealthandrights.com/resource-library/national-policy-brief-navigating-human-rights-and-risks-online-young-ghanaians-and-the-future-of-digital-health/Vietnam policy brief DHRP: https://digitalhealthandrights.com/resource-library/paying-the-cost-of-connection-vietnam-policy-brief/Ghana law: https://en.wikipedia.org/wiki/Ghanaian_anti-LGBTQ_bill

How do you introduce AI into one of the world's most regulated industries? Dan Herron, Global VP of Digital Health at RWS, joins the Cultural Intelligence Podcast to discuss how life sciences teams can responsibly apply AI in clinical operations, COAs, and linguistic validation: * Why life sciences is uniquely complex for AI adoption, and why regulation, bias, and documentation matter so much * How AI can support faster workflows in low risk areas (green zones), while a human in the loop remains essential for patient facing and regulated content (red zones) * Why the future of linguistic validation is about responsible modernization, not automation for its own sake A conversation on AI with guardrails, the human in the loop imperative, and why the industry can't afford to wait for someone else to go first.

As concerns escalate about the deadly Ebola virus outbreak in Africa, we bring you the unique insights of Dr. Peter Piot, a renowned microbiologist who co-discovered the virus 50 years ago during the first recorded outbreak of the disease. His on-the-ground account of that crisis was provided to us in April before the current outbreak was declared, but it contains valuable historical perspective and shares lessons learned that he carried forward in his consequential career.  “What I saw from the beginning is the most important thing is to listen to people and that you need to act fast to save lives, before you have the evidence you would like to have.”    He followed his contributions on Ebola by diving into the fight against HIV/AIDS, eventually reshaping global response in leadership roles at the World Health Organization and United Nations. As he shares with host Lindsey Smith, the learnings in that case were more pragmatic than scientific. “We had to redefine HIV/AIDS not as a medical problem but as an economic and security problem in order to get it on the political agenda.”  Tune in for a fascinating episode that takes you from the gritty frontlines of public health crises to the battles for funding and attention in the halls of power as Dr. Piot shares what it actually takes to move the world to respond effectively to health threats. Mentioned in this episode: London School of Hygiene & Tropical Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this Hot Topics episode, Louise joins from London after an unexpected encounter with the UK healthcare system, while George reports back from the Digital Health Festival.The pair discuss New Zealand's $450 million digital health and cyber investment, a major new King's College London study showing one in seven people are already using AI instead of seeing a doctor, Demis Hassabis' bold prediction that we're entering the "foothills of the singularity", and two emerging AI approaches aimed at predicting serious disease before symptoms appear.Plus, a shout-out to Australian health tech company ThinkMD.ai for winning international recognition at the World Health Assembly.Topics covered:New Zealand's renewed investment in digital health and cyber security Why patients are increasingly turning to AI before healthcare professionals Public trust, regulation and the future of clinical AI Google's vision for AI-driven scientific discovery Predicting liver disease years earlier using historical pathology data Longevity science and AI-powered disease prediction What healthcare needs to do to keep pace with accelerating technological changeResources:Stryker Vocera's Initial Delays Diagnosis Quiz LinkDigital Health Workforce Census (opens 1 May, ANZ) LinkHospital Sant Pau, Barcelona LinkThe Use of AI in UK Healthcare Report, King's College London LinkWHO endorses precision medicine resolution LinkCongrats to ThinkMD.ai and Dr Jackie Rabec – Pulse+IT LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

98% of patients welcome AI in their care — and still want a human in charge. That tension ran through the OECD and Spanish Ministry of Health conference on scaling AI in health (Madrid, late May 2026), and it frames this episode of Faces of Digital Health. Out of 38 OECD countries, only seven have a formal AI strategy and just over a tenth run workforce upskilling programmes — the ambition is outrunning the institutions meant to govern it. Host Tjaša Zajc brings together voices from across the conference to ask what actually has to change: regulation, trust, who gets a seat at the table, and the parts of the agenda nobody is funding. Featuring: - Eric Sutherland — Senior Economist, OECD - Aferdita Bytyqi — Executive Director & Founding Partner, Digital Transformations for Health Lab (DTH-Lab) - Erza Selmani — Research Fellow, DTH-Lab - Valentina Strammiello — Executive Director, European Patients Forum (EPF) - Dr Ricardo Baptista Leite — CEO, HealthAI (the Global Agency for Responsible AI in Health) - Dr Persephone Doupi — Senior Medical Officer, Finnish Institute for Health and Welfare; President, European Federation for Medical Informatics (EFMI) What the conversation covers: - Why trust — not capability — is the binding constraint on health AI adoption - The OECD readiness gap: AI strategies, HTA frameworks and workforce upskilling - How patients really feel about AI: consent forms, transparency, and keeping clinicians central - Why youth health and wellbeing keep getting left out of AI governance frameworks - Five recommendations to make the EU AI Act work for health and competitiveness - Coordinating the EU AI Act, MDR/IVDR and the European Health Data Space - Health technology assessment and reimbursement as the real barriers to scale - AI literacy and prevention: the most underweighted lever in the room Chapters: 0:10 — Welcome: AI in Health & the 2026 OECD Conference in Madrid 0:25 — Key Stats: Only 7 of 38 OECD Countries Have a Formal AI Strategy 2:10 — Eric Sutherland (OECD): We're Not Using Data as Effectively as We Could 3:11 — Afrodita & Erza (DTH Lab): Youth Health Is Missing from AI Governance Frameworks 5:12 — Valentina Stramello (EPF): 98% of Patients Are Positive About AI, But Trust Requires Transparency 7:14 — Dr. Ricardo Baptista Leite (Health AI): 5 Recommendations to Fix EU AI Policy for Health 10:53 — Persephone Doupi (EFMI): We Must Prioritize AI Literacy and Shift Healthcare Toward Prevention —

Send us Fan MailWhat if the tools patients use between therapy sessions mattered more than the sessions themselves?In this clip from our episode “Fixing the Access Crisis In Mental Health”, host John Driscoll and Mark Frank, Co-Founder and CEO of SonderMind, break down how a fully integrated platform combining 80 digital interventions with an AI coach is producing outcomes up to 275% better than traditional therapy alone.Listen to the full episode here

Send us Fan MailAmerican hospitals now spend nearly $2 on administrative overhead for every dollar that touches direct patient care. Insurers earn billions in float by sitting on claims for weeks, providers borrow money just to stay liquid, and patients open bills for visits they barely remember.Don Peterson, Founder and CEO of PIM Health, joins host David E. Williams to discuss why healthcare's payment system is working exactly as it was designed to work, and how real-time claims adjudication at the point of care could eliminate prior authorization as it currently exists, cut administrative overhead from 12 to 15 percent down to 2 to 3 percent, and return hundreds of billions of dollars in waste back to patients, providers, and plan sponsors.

In the late 1980s, a child exposed to fallout from the Chernobyl disaster lay in a hospital bed while doctors told his family there were no clear answers and no reliable path forward. Decades later, that same child, Yan Leyfman, walks into exam rooms as a hematology oncology fellow, expected to deliver clarity inside a system that still runs on delay, uncertainty, and institutional self preservation.This episode traces the throughline from early life shaped by radiation exposure and hospice level uncertainty to a career inside academic medicine, translational research, and oncology media. Yan built his identity around survival and usefulness, moving from patient to physician while carrying the memory of what it feels like to sit on the other side of the table. He helped launch MedNews Week during the COVID crisis to push back on misinformation and expand access to medical knowledge, stepping into a public role while still in training.The conversation stays grounded in the friction between personal narrative and system reality. Clinical training demands efficiency, hierarchy, and emotional distance. Cancer care demands time, clarity, and human connection. Those forces collide in real patient encounters where prior authorization delays, insurance barriers, and fragmented care pathways shape outcomes as much as any treatment protocol.Yan speaks openly about mentorship, belonging, and the drive to make meaning out of survival. The discussion pushes further into what the healthcare system actually rewards, what it quietly strips away, and how quickly empathy can erode under institutional pressure. The episode also examines the role of medical media, where education, industry influence, and narrative control often blur together.This is a conversation about identity under construction, about what happens when someone who remembers powerlessness steps into a role that carries authority, and about whether that memory can survive long enough to change anything.RELATED LINKSYan Leyfman on LinkedInYan Leyfman on InstagramSurviving ChernobylFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Health Affairs Publishing's Rob Lott speaks to Abe Sutton, Director of the Center for Medicare and Medicaid Innovation, about the ACCESS model and broader efforts to test payment and delivery reforms aimed at improving affordability, expanding digital health, and generating real-world evidence in Medicare. Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.

Healthcare is simultaneously propping up the US economy and facing one of its most uncertain moments in years.This month, Halle and Steve unpack the growing contradictions shaping digital health right now: healthcare jobs are driving nearly half of US job growth while provider bankruptcies surge, AI is flooding into healthcare faster than regulators can keep up, and Washington continues to send mixed signals on the future of healthcare policy and innovation.We cover:Why healthcare jobs are now carrying the US labor market and what Medicaid cuts could mean for the economyThe surprising comeback of wearables and how companies like Whoop, Oura, and Google are building massive subscription businessesCMS's new ACCESS model and the debate over whether AI-driven care can actually lower costs without sacrificing qualityThe lawsuit against Character.AI and what it reveals about the growing demand for AI mental health toolsWhy investors are pouring billions into AI drug discovery despite huge unanswered questions about clinical developmentMarty Makary's resignation from the FDA and what ongoing instability means for biotech, pharma, and healthcare innovation—Show notes:Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. (WSJ)Oura Debuts Ring 5, Ahead of Potential IPO (WWD)Whoop Raises $575 Million at $10.1 Billion Valuation (Whoop)Fitbit Ditches the Screen With Its New $99 Whoop Rival (PC Mag)Why big digital health players are missing from Medicare's chronic care experiment (STAT)Character.AI Lawsuit (PA.gov) Marty Makary out as FDA chief (Axios)—

Learn more about Fibion Student Lab: https://fibion.com/studentlab For any questions and quote, please contact Dr Miriam Cabrita at miriam.cabrita@fibion.com --- Dr Miriam Cabrita has done her Bachelor and Master degrees at NOVA School of Science and Technology in Portugal, and her PhD in biomedical engineering in University of Twente Then she has worked at Roessingh Research and Development Center in Netherlands for 8 years coordinating and managing EU research projects related to eHealth Teaching also courses on Physical Activity, Digital Health and Virtual Coaching at the University of Twente. She has acted as a Board Member for 5 years in International Society for the Measurement of Physical Behaviour (ISMPB) Currently she is working as a Chief Customer Officer at Fibion Inc. _____________________ This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS --- SB and PA measurements, analysis, and feedback made easy.  Learn more about Fibion Research --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Collect self-report physical activity data easily and cost-effectively with Mimove. --- Explore our Wearables,  Experience sampling method (ESM), Sleep,  Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow Fibion on Twitter https://twitter.com/fibion https://www.youtube.com/@PA_Researcher

Matthew Zachary is a brain cancer survivor, healthcare advocate, founder of Stupid Cancer and We the Patients, and host of Out of Patients. In April 2026, he returned to the stage at Merkin Hall near Lincoln Center for his first solo public piano concert in almost 22 years while launching his debut book, We the Patients: Understanding, Navigating, and Surviving America's Healthcare Nightmare.What unfolded became far larger than a concert.Over 2 hours, survivors, clinicians, advocates, nonprofit founders, journalists, pharmaceutical sponsors, and healthcare insiders gathered in one room to reflect on 30 years of survivorship, institutional failure, accidental advocacy, and the emotional afterlife of cancer. The evening moved through original piano performances, live chapter readings, and deeply personal conversations about infertility, disability, financial toxicity, insurance denials, grief, burnout, and what happens when patients spend decades navigating systems designed around transactions instead of continuity.Guests including Wendell Potter, Maimah Karmo, Craig Lustig, Shelly Fuld Nasso, Tamika Felder, and others reflected on how the modern cancer advocacy movement emerged largely because patients built parallel systems where healthcare infrastructure failed to meet human needs. The conversation explored how prior authorization, reimbursement incentives, administrative fragmentation, and institutional distrust continue shaping the patient experience across oncology and survivorship.The performance also marked a deeply personal milestone. After brain cancer compromised his left hand at age 21, Zachary spent 6 months rehabilitating both hands to return to public performance for the first time in over 2 decades. The result became part concert, part civic gathering, and part historical record of a generation of survivors who refused to disappear quietly.RELATED LINKSMZLIVE Official WebsiteMZLIVE YouTube VideoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Brian Hasselfeld, MD, Executive Medical Director, Digital Health and Innovation, Associate Director, Johns Hopkins inHealth, Johns Hopkins Medicine, and Primary Care Physician, Johns Hopkins Community Physicians, shares his unconventional journey from investment banking to medicine and discusses how artificial intelligence and digital health are reshaping care delivery.

Send us Fan MailMore than 160 million Americans live in federally designated mental health provider shortage areas. Even those with insurance often spend months searching for a therapist who takes their plan and has availability.Mark Frank, Co-Founder and CEO of SonderMind, joins host John Driscoll to discuss why fixing the provider infrastructure had to come before solving patient access, and how a fully integrated platform combining measurement-based care with AI-powered tools between sessions is producing outcomes up to 275% better than traditional therapy alone.

Send us Fan MailFor most small businesses, health insurance is their second or third largest expense. And they usually find out what it's going to cost them two to three weeks before renewal.In this clip from our episode “Why Health Insurance Needs Transparency”, host John Driscoll and Ty Wang, Co-Founder and CEO of Angle Health, break down why unpredictable premium increases make it nearly impossible for small businesses to plan, and why the market has accepted this as normal for far too long.Listen to the full episode here

What type of projects want to measure PA? Considerations when choosing an activity tracker grouped in three main topics: Participant-centric: Research and innovation driven Regulatory Dr Miriam Cabrita has done her Bachelor and Master degrees at NOVA School of Science and Technology in Portugal, and her PhD in biomedical engineering in University of Twente Then she has worked at Roessingh Research and Development Center in Netherlands for 8 years coordinating and managing EU research projects related to eHealth Teaching also courses on Physical Activity, Digital Health and Virtual Coaching at the University of Twente. She has acted as a Board Member for 5 years in International Society for the Measurement of Physical Behaviour (ISMPB) Currently she is working as a Chief Customer Officer at Fibion Inc. _____________________ This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Learn more about Fibion Sleep and Circadian Rhythm Solutions: https://sleepmeasurements.fibion.com/ --- Collect, store and manage SB and PA data easily and remotely - Discover groundbreaking Fibion SENS: https://sens.fibion.com/ --- SB and PA measurements, analysis, and feedback made easy.  Learn more about Fibion Research : fibion.com/research --- Follow Fibion on Twitter https://twitter.com/fibion Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow the podcast on Twitter https://twitter.com/PA_Researcher  

In December 1996, a 37 year old pharmaceutical executive sat in a Borders bookstore reading medical textbooks on the floor, trying to understand a disease she had never heard of. Multiple myeloma carried a three year prognosis. Her daughter was 18 months old. Her father had just died of cancer. Within weeks, she pushed her doctors to say the quiet part clearly. This would likely end her life before her child entered kindergarten.Kathy Giusti refused to accept passive survival. She built a plan while the system offered fragments. She interviewed oncologists and fertility specialists at the same time. She pursued IVF to have a second child while preparing for treatment. She stayed employed to keep insurance coverage. Every decision carried financial, medical, and emotional risk.That same urgency exposed a deeper failure. Cancer research moved slowly. Academic centers guarded data. Clinical trials lacked coordination. Patients entered a system that demanded compliance without providing clarity. Giusti responded by building the Multiple Myeloma Research Foundation, not as a support group, but as an operating engine to accelerate drug development, fund research, and force collaboration across institutions.This episode tracks the tension between individual agency and systemic failure. Giusti describes how patients navigate diagnosis, insurance barriers, and fragmented care in real time. She explains how data, genomics, and clinical trials reshape cancer treatment while still leaving patients responsible for decisions they are not trained to make. She addresses disparities in access, the limits of early detection, and the reality that progress in oncology often depends on speed, funding, and alignment of incentives.The conversation moves between lived experience and structural critique. It names the cost of delay, the burden placed on patients to act as their own advocate, and the tradeoffs required to push a system forward that still protects itself first.⸻RELATED LINKSKathy GiustiMultiple Myeloma Research FoundationFatal to FearlessAmerican Society of Hematology⸻FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The ongoing outbreak of hantavirus infections that originated with passengers on the Dutch cruise ship MV Hondius in April has generated concerns across the globe. This very rare occurrence has led to a number of deaths, required quarantining of passengers and prompted emergency responses from public health authorities in multiple countries.  On this episode of Raise the Line from Elsevier, we're tapping the expertise of a leading authority on the subject, Dr. Jamie Childs of Yale University, to provide you with a scientific understanding of hantaviruses and what level of threat is posed by this situation. In short, Dr. Childs believes this is not the start of a pandemic. “The Andes variant involved here is one of the most dangerous hantaviruses, but it is totally controllable with contact tracing.” This timely conversation with host Lindsey Smith is informed by Dr. Childs' decades of hantavirus research as well as learnings from his role leading the CDC's environmental investigation during the landmark 1993 hantavirus outbreak in the Four Corners region of the American Southwest. And be sure to stay tuned to hear his concerns about the factors complicating containment of the current Ebola outbreak in East Africa. Note: this conversation was recorded on May 19th, 2026. Mentioned in this episode: Yale School of Public Health Yale Institute for Global Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Doctors are using ChatGPT in clinic right now — and some of them don't care about privacy. Three operators on what that means for healthcare AI. Recorded live at health.tech in Basel, this panel from Faces of Digital Health unpacks the convergence reshaping clinical software: ambient AI scribes, agentic AI in healthcare, on-device LLMs, and the regulatory drag (MDR, EU AI Act, EHDS) that is widening the gap between what clinicians actually use and what hospitals are allowed to buy. Host Tjaša Zajc is joined by: Jonathan Bringas — CEO & Founder, Lapsi Health (Kaiku: FDA-cleared AI stethoscope, ambient scribe and clinical assistant in one device) Blaž Triglav — CEO, Mediately (drug information platform, 1M+ HCPs across Europe) Amanda Herbrand — Clinical data modelling consultant, formerly University Hospital Basel What the conversation covers: — Why EHR data fragmentation is the precondition AI hasn't solved — Shadow AI: why clinicians trust ChatGPT more than enterprise tools (and the agency hypothesis behind it) — The convergence of stethoscopes, scribes, drug information and decision support into one workflow layer — ROI in healthcare AI: financial, time, clinical accuracy — and Herbrand's fourth dimension, user satisfaction — "Doctors were the original vibe coders": the 2,000 Excel spreadsheets running European hospitals — Why FDA-cleared beats MDR in 2026 sales cycles, and what Chile's regulatory minimalism tells us — The asymmetry that will break European medtech: applicants using AI to build, regulators forbidden from using AI to assess — On-device AI, ambient computing, AGI in clinical workflows — and the de-skilling risk no one wants to discuss ⏱ Chapters 00:00 — Opening: AI agents, vibe coding, and what doctors actually want 01:30 — Data fragmentation: the precondition AI hasn't solved (Amanda Herbrand) 02:30 — Keiku: collapsing stethoscope, scribe and assistant into one device 05:15 — The convergence reshaping healthcare AI — and the shadow AI in clinic 07:30 — Why doctors trust ChatGPT more than enterprise tools: the agency hypothesis 10:30 — ROI: financial, time, clinical accuracy — and Herbrand's fourth dimension 15:30 — Choosing solutions: modular requirements and FDA-cleared moats 19:30 — EHDS and the missing connector in European standardisation 21:00 — "Doctors were the original vibe coders": the 2,000 spreadsheet problem 24:30 — The two-speed world: regulated medicine vs the Wild West 28:00 — Why Chile's regulatory minimalism beats Europe's MDR 30:30 — Agentic AI vs regulators: the asymmetry that will break European medtech 33:30 — On-device AI, AGI, and the deskilling no one wants to discuss

Sa gitna ng burnout at workforce shortage, virtual nursing na ba ang kinabukasan ng healthcare? Sa podcast na ito, alamin kung paano nagbubukas ng bagong oportunidad ang virtual healthcare para sa mga Filipino nurses, kabilang ang mga dating OFWs at healthcare workers sa Pilipinas, at kung paano binabago ng teknolohiya ang tradisyunal na imahe ng nursing.

Most careers don't follow a straight line. But few require starting over in full view of the public.This week, Halle sits down with Lance Armstrong to discuss how he rebuilt his life and career after multiple turning points, including surviving advanced cancer, and how those experiences shaped his perspective on health, performance, and reinvention. Now, through his venture firm Next Ventures, he backs companies focused on what they call “whole person health” — spanning prevention, wellness, diagnostics, longevity, and healthcare outside the traditional system.We cover:Why he chose to become a VC, and what he likes (and dislikes) about the jobHow his experience as a patient shapes how he evaluates companiesWhy preventive care is growing outside the traditional healthcare systemWhat he looks for in founders building across the care continuumWhat it takes to rebuild trust and start overAbout our guest:Lance Armstrong is a former professional cyclist, entrepreneur, and investor. After surviving advanced testicular cancer, he founded Livestrong, helping raise more than $500 million to support cancer patients and survivors worldwide. In 2019, he co-founded Next Ventures, a venture capital firm focused on health, wellness, and consumer brands, with investments including Oura, Cofertility, Pair Team, and SteadyMD. Prior to Next Ventures, he was an active angel investor in companies such as Uber, DocuSign, and Athletic Brewing.—

Five Good Things Join us for Five Good Things with Janae Sharp and Megan Antonelli: A rapid-fire segment highlighting positive developments in digital health. Janae and Megan share insights on recent innovations, successful implementations, and emerging trends that are driving progress in healthcare technology. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Nursing at the Center: How AI, Virtual Care, and Human-Centered Design Are Transforming the Bedside at Advocate Health Host: Megan Antonelli Guest: Tracy Breece, MSN, RN, CENP, NI-BC, CPHIMS, Vice President Nursing Innovation, AI, & Emerging Technologies, Advocate Health At Advocate Health, nursing is not adapting to AI. Nursing is driving the adoption. Tracy Breece, VP of Nursing Innovation, AI and Emerging Technologies, shares how one of the nation's largest health systems is building the hospital room of the future with nurses at the center of every design decision, workflow, and implementation strategy. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us Fan MailNearly half of all Americans get their health insurance through a small business. Most of those businesses have no idea why their premiums go up every year and no real power to do anything about it.Ty Wang, Co-Founder and CEO of Angle Health, joins host John Driscoll to discuss why legacy insurers benefit from keeping small businesses in the dark on costs, and how rebuilding the health plan stack from the ground up on modern, AI-native infrastructure is finally making transparency and customization possible for the employers who have always needed it most.

Tim Elliott is the CEO of Navvis, a value-based enablement company that works with health systems, health plans, physician groups, and employers to drive performance under value-based agreements. Navvis takes a cross-continuum view of care — supporting patients before, during, and after the physician visit — and operates across the full spectrum of payment models, from full-risk MA and MSSP ACOs to bundled payments, TEAMS, and CJR. Tim's core conviction is that physicians are the linchpin of any sustainable change in value-based care, and that the "last mile" of transformation is change management — not technology. Navvis doesn't show up with a blank piece of paper or a mandatory platform; they bring a point of view on what world-class looks like and engage physicians in the refinement and rollout.We discuss:What AI consistently misses in value-based care — and why "human in the loop" needs to be on steroids in healthcare, not just a check on the modelHow to recognize when a health system is rolling tools out faster than clinicians can absorb them — and why bottom-up physician demand is reshaping the AI rollout playbookThe real difference between a care model physicians co-designed and one that was handed to them — and how Navvis approaches refinement vs. a blank-paper exerciseWhat surprises health systems most when they move into real downside risk for the first time — the misalignment between contract incentives and operational behaviorWhy "two standards of care" is the wrong frame for value-based vs. fee-for-service patients — and what the EMR needs to recognize at the point of encounterThe alignment problem at the executive and physician level that quietly kills downside-risk contracts before the year is outThe lesson Tim hopes the industry finally learns 20 years from now — why the 3-5% of patients driving 60-80% of cost are the unfinished work of this eraWho Navvis is built for, and why their model is to optimize existing technology rather than force a 12-to-18-month rip-and-replace— Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations. — Where to find Jared: • X: https://x.com/jaredstaylor • LinkedIn: https://www.linkedin.com/in/jaredstaylor/

We mark National Mental Health Awareness Month on this episode by tapping the expertise of Dr. Steve Strakowski, an internationally recognized expert in bipolar disorder, who has spent decades studying the neurobiology and treatment of mood conditions while pushing just as hard on the structural barriers that keep effective treatments out of reach for more than half the people who need them. In this conversation with Raise the Line from Elsevier host Michael Carrese, Dr. Strakowski explains why access, not science, is now the biggest obstacle to improving mental health outcomes. He also addresses the heavy toll society pays for underfunding mental health prevention and treatment programs. “The money is spent eventually, but in the most expensive places like emergency rooms and prisons, and there is the human cost of suffering and suicides." This important discussion also covers: The persistent problem of Black patients presenting with mania being misdiagnosed with schizophrenia;  Why he describes bipolar disorder as a reward-processing illness;  The emerging therapies he finds encouraging. Mentioned in this episode:Indiana University School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Today we're doing lunch at Manhatta, towering 60 stories above the financial district. Joining us is Rick Heitzmann, co-founder and partner at one of New York's most influential early stage venture firms, First Mark Capital.  Rick has been early to some of the most category defining companies of the last decade, backing names like Pinterest, Airbnb, and DraftKings. That foresight has landed him on the Forbes Midas list, not once, not twice, but five times. And if that wasn't enough, he's living the dream of every New York sports fan, joining the ownership group of the New York Yankees. Timecodes: 00:00 – Cold open: The Vilification of AI 01:08 – Meet Rick Heitzmann 03:18 - Philly Sports Fan Turned Yankees Owner 05:02 - How Rick Got Into Yankees Ownership 06:00 - Spotting Trends Early: DraftKings, Airbnb & Pinterest 07:50 - Sports Betting, Prediction Markets & Integrity in Sports 09:40 - Danny Meyer, Hospitality & NYC Restaurant Culture 11:27 - Why the Restaurant Business Is So Tough Right Now 12:46 - AI, Digital Health & The Future of Healthcare 15:45 - The Explosion of Women's Sports & Sports Merch Culture 18:02 - The Great Jersey Debate: Should Adults Wear Them? — FOLLOW US Instagram: riskreversalmedia   Twitter: https://x.com/riskreversal LinkedIn: riskreversalmedia   #investing #stocks #stockmarket #ApexFintechSolutions Standing Table is made possible through our continued partnership with Apex Fintech Solutions. Apex Fintech Solutions provides the tools and services that enable hundreds of clients to launch, scale, and support digital investing for tens of millions of end investors. The company provides essential infrastructure and a comprehensive ecosystem of cloud-based products to enable and streamline trading, wealth management, cost basis, tax reporting, and, through its subsidiary Apex Clearing™, custody and clearing. For more information, visit the Apex Fintech Solutions website: https://apexfintechsolutions.com/ LinkedIn: apex-fintech SUBSCRIBE: RiskReversal Pod for more from Guy and Dan: https://apple.co/3RzvgpD RiskReversal Media channel for more episodes and content:    / @riskreversalmedia   The financial opinions expressed in Risk Reversal content are for information purposes only. The opinions expressed by the hosts and participants are not an attempt to influence specific trading behavior, investments, or strategies. Past performance does not necessarily predict future outcomes. No specific results or profits are assured when relying on Risk Reversal. Before making any investment or trade, evaluate its suitability for your circumstances and consider consulting your own financial or investment advisor. The financial products discussed in Risk Reversal carry a high level of risk and may not be appropriate for many investors. If you have uncertainties, it's advisable to seek professional advice. Remember that trading involves a risk to your capital, so only invest money that you can afford to lose. Derivatives are not suitable for all investors and involve the risk of losing more than the amount originally deposited and any profit you might have made. This communication is not a recommendation or offer to buy, sell or retain any specific investment or service.​​

At 19, Shlomit woke up unable to speak. The right side of her body went numb. An emergency room sent her home and called it stress. That moment did not end in a diagnosis that changed policy or triggered reform. It sent her into a decade long pursuit of understanding how the brain fails language and how the healthcare system fails patients who cannot advocate for themselves.Shlomit trained as a speech language pathologist and spent years inside acute care hospitals and ICUs, performing endoscopies and treating patients with brain injury, stroke, and dysphagia. She watched medical teams rotate in and out, deliver dense updates, and leave families nodding without comprehension. She stayed behind and translated. Every day, patients told her she was the only one who explained what was happening. That gap is not an accident. Hospital systems optimize for throughput, not understanding. Patients move through beds based on cost, not readiness. Discharge planning becomes a financial decision wrapped in clinical language. A stay under 48 hours can shift the insurance burden dramatically, leaving patients exposed to higher out of pocket costs. Shlomit left the system and built Patient Path NYC, a private patient advocacy service. She now spends 15 to 20 hours a week per client reading charts, coordinating care teams, and translating medical decisions into plain language. Her work sits in the uncomfortable space between healthcare policy and lived experience. Families pay out of pocket to understand their own care. Hospitals benefit from the clarity she provides while maintaining the same structural incentives that created the confusion.This conversation tracks the human cost of fragmented care, the economics behind discharge decisions, and the quiet reality that patients who cannot communicate clearly often lose control of their own outcomes.RELATED LINKSShlomit LibertyShlomit Liberty on LinkedInPatient Path NYCBoard Certified Patient AdvocateFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.